Progression-free Survival After Second Line of Therapy for Metastatic Clear Cell Renal Cell Carcinoma in Patients Treated with First-line Immunotherapy Combinations
- Resource Type
- Short Communication
- Source
- In
European Urology March 2023 83(3):195-199 - Subject
- Language
- ISSN
- 0302-2838